Vistagen Therapeutics, Inc. Quarterly Deferred Tax Assets, Operating Loss Carryforwards in USD from Q1 2012 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.
Summary
Vistagen Therapeutics, Inc. quarterly Deferred Tax Assets, Operating Loss Carryforwards history and growth rate from Q1 2012 to Q1 2024.
  • Vistagen Therapeutics, Inc. Deferred Tax Assets, Operating Loss Carryforwards for the quarter ending March 31, 2024 was $46.5M, a 6.56% increase year-over-year.
Deferred Tax Assets, Operating Loss Carryforwards, Quarterly (USD)
Deferred Tax Assets, Operating Loss Carryforwards, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $46.5M +$2.86M +6.56% Mar 31, 2024 10-K 2024-06-11
Q1 2023 $43.6M +$1.68M +4% Mar 31, 2023 10-K 2024-06-11
Q1 2022 $41.9M +$8.34M +24.8% Mar 31, 2022 10-K 2023-06-28
Q1 2021 $33.6M +$2.98M +9.74% Mar 31, 2021 10-K 2022-06-23
Q1 2020 $30.6M +$3.42M +12.6% Mar 31, 2020 10-K 2021-06-29
Q1 2019 $27.2M +$5.79M +27% Mar 31, 2019 10-K 2020-06-30
Q1 2018 $21.4M -$8.78M -29.1% Mar 31, 2018 10-K 2019-06-25
Q1 2017 $30.2M +$3.58M +13.4% Mar 31, 2017 10-K 2018-06-26
Q1 2016 $26.6M +$3.55M +15.4% Mar 31, 2016 10-K 2017-06-29
Q1 2015 $23.1M +$23M Mar 31, 2015 10-K 2016-06-24
Q1 2014 $19.7K* +$723 Mar 31, 2014 10-K 2015-06-29
Q1 2013 $19K* -$143K Mar 31, 2013 10-K 2014-06-25
Q1 2012 $162K Mar 31, 2012 10-K 2013-07-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.